Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs designed to target Alzheimer's.

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...

Using advanced artificial intelligence algorithms, scientists are hoping to identify brain wave patterns associated with the ...

The findings suggest that symptoms of Alzheimer's are closely linked to the makeup of the gut. Today, evidence strongly ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said its Kisunla for the treatment of adults with early symptomatic Alzheimer's disease has been approved by the Ministry of Health, Labour and Welfare ...

A diagnosis in the early stages may allow you to start treatments that can slow disease progression.

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s ...

The Dutch company has created a device for the early detection of Alzheimer’s disease, and it is on its way to developing ...

Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold ...

Understanding the link between mental health and Alzheimer's is crucial, as studies show that depression may raise the risk ...

A new study finds sleeping on your back could increase your risk for neurodegenerative disorders, such as Alzheimer’s disease ...